Financing & Capital Markets
MTS specializes in negotiated financings for life sciences companies, delivering customized equity solutions across all stages of growth. Our experienced team combines deep investor relationships with a tailored, high-effort approach that drives precise outcomes.
Our Approach
Long-term Investor Relationships Grounded in Trust, Transparency, and Alignment. We Ensure Every Transaction Meets Our Clients’ Unique Goals.
MTS has built and expanded a specialized Negotiated Financing Platform focused on the life sciences sector. We provide a tailored approach to equity financing – spanning private venture rounds, PIPEs, SPAC-related fundraisings, IPOs, and CMPOs – designed to meet each company’s unique needs.
Our process is highly customized, emphasizing thoughtful positioning, targeted investor engagement, and strategic deal structuring. Every transaction is driven by a “high effort, low volume” philosophy that prioritizes precision, creativity, and results over scale.
Led by a cohesive team with deep relationships and long tenures in the healthcare investment community, MTS manages every aspect of the financing process – from investor outreach to execution – with unmatched expertise and commitment. This approach consistently positions our clients for outcomes anchored by leading healthcare specialist investors.
Our Investor Relationships
A Deep Network Spanning Healthcare Specialists Across Capital Markets
- Venture Capital
- Hedge Funds
- Cross-Over & Multi-Specialty Funds
- Private Equity
- Royalty Buyers
- Private Credit
